| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 5,453 | 3,961 | 6,091 | 16,479 | | Cost of Revenue | 3,536 | 3,443 | 4,024 | 12,037 | | | Gross Profit | 1,917 | 518 | 2,067 | 4,442 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,639 | 1,462 | 4,800 | 7,505 | | Non Recurring | (1,018) | 1,018 |
-
| 10,831 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (704) | (1,962) | (2,733) | (13,894) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,161) | (1,962) | (2,733) | (13,894) | | Interest Expense | (151) | 135 | 16 | 207 | | Income Before Tax | (1,010) | (2,097) | (2,749) | (14,101) | | Income Tax Expense | 9 | 37 | (28) | 104 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,019) | (2,134) | (2,721) | (14,205) | | | Non-recurring Events | | Discontinued Operations | 1,079 | (2,981) | (241) | (698) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 60 | (5,115) | (2,962) | (14,903) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $60 | ($5,115) | ($2,962) | ($14,903) |
|
0.26% Nasdaq 
Income Statement
